Annual EBITDA
-$56.73 M
-$9.62 M-20.41%
December 31, 2022
Summary
- As of February 10, 2025, CFRX annual EBITDA is -$56.73 million, with the most recent change of -$9.62 million (-20.41%) on December 31, 2022.
- During the last 3 years, CFRX annual EBITDA has fallen by -$29.04 million (-104.84%).
Performance
CFRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$6.64 M
+$1.30 M+16.33%
September 1, 2023
Summary
- As of February 10, 2025, CFRX quarterly EBITDA is -$6.64 million, with the most recent change of +$1.30 million (+16.33%) on September 1, 2023.
- Over the past year, CFRX quarterly EBITDA has increased by +$7.50 million (+53.06%).
Performance
CFRX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$30.05 M
+$7.50 M+19.98%
September 1, 2023
Summary
- As of February 10, 2025, CFRX TTM EBITDA is -$30.05 million, with the most recent change of +$7.50 million (+19.98%) on September 1, 2023.
- Over the past year, CFRX TTM EBITDA has increased by +$34.06 million (+53.12%).
Performance
CFRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CFRX EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -20.4% | +53.1% | +53.1% |
3 y3 years | -104.8% | +8.7% | -0.7% |
5 y5 years | -115.1% | +14.5% | -8.5% |
CFRX EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | +20.4% | at low | at high | +201.1% | at high | +113.3% |
5 y | 5-year | +104.8% | at low | +3.3% | +201.1% | +8.5% | +113.3% |
alltime | all time | +246.3% | at low | +161.3% | +201.1% | +609.9% | +113.3% |
ContraFect EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2023 | - | -$6.64 M(-16.3%) | -$30.05 M(-20.0%) |
Jun 2023 | - | -$7.93 M(-10.0%) | -$37.56 M(-24.3%) |
Mar 2023 | - | -$8.82 M(+32.3%) | -$49.61 M(-12.6%) |
Dec 2022 | -$56.73 M(+20.4%) | -$6.67 M(-52.9%) | -$56.73 M(-11.5%) |
Sep 2022 | - | -$14.14 M(-29.3%) | -$64.11 M(+4.0%) |
Jun 2022 | - | -$19.99 M(+25.4%) | -$61.62 M(+17.8%) |
Mar 2022 | - | -$15.94 M(+13.5%) | -$52.30 M(+11.0%) |
Dec 2021 | -$47.12 M(+38.3%) | -$14.04 M(+20.6%) | -$47.12 M(+7.7%) |
Sep 2021 | - | -$11.65 M(+9.2%) | -$43.73 M(+11.1%) |
Jun 2021 | - | -$10.67 M(-0.8%) | -$39.35 M(+6.9%) |
Mar 2021 | - | -$10.76 M(+0.9%) | -$36.80 M(+8.0%) |
Dec 2020 | -$34.07 M(+23.0%) | -$10.66 M(+46.5%) | -$34.07 M(+14.2%) |
Sep 2020 | - | -$7.27 M(-10.4%) | -$29.84 M(-1.0%) |
Jun 2020 | - | -$8.12 M(+1.2%) | -$30.15 M(+2.6%) |
Mar 2020 | - | -$8.02 M(+24.8%) | -$29.40 M(+6.1%) |
Dec 2019 | -$27.70 M(-10.6%) | -$6.43 M(-15.2%) | -$27.70 M(-7.9%) |
Sep 2019 | - | -$7.58 M(+3.0%) | -$30.07 M(-0.6%) |
Jun 2019 | - | -$7.37 M(+16.5%) | -$30.25 M(-0.3%) |
Mar 2019 | - | -$6.32 M(-28.2%) | -$30.34 M(-2.0%) |
Dec 2018 | -$30.97 M | -$8.80 M(+13.4%) | -$30.97 M(+4.9%) |
Sep 2018 | - | -$7.76 M(+4.0%) | -$29.52 M(+3.7%) |
Jun 2018 | - | -$7.46 M(+7.3%) | -$28.45 M(+5.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2018 | - | -$6.95 M(-5.4%) | -$27.03 M(+2.5%) |
Dec 2017 | -$26.38 M(-20.3%) | -$7.35 M(+9.8%) | -$26.38 M(+2.8%) |
Sep 2017 | - | -$6.69 M(+10.9%) | -$25.67 M(-4.0%) |
Jun 2017 | - | -$6.03 M(-4.2%) | -$26.75 M(-11.9%) |
Mar 2017 | - | -$6.30 M(-5.2%) | -$30.36 M(-8.2%) |
Dec 2016 | -$33.08 M(+34.9%) | -$6.64 M(-14.6%) | -$33.08 M(-2.1%) |
Sep 2016 | - | -$7.78 M(-19.4%) | -$33.79 M(+6.9%) |
Jun 2016 | - | -$9.64 M(+6.9%) | -$31.60 M(+9.0%) |
Mar 2016 | - | -$9.02 M(+22.7%) | -$28.99 M(+18.2%) |
Dec 2015 | -$24.53 M(+49.7%) | -$7.35 M(+31.7%) | -$24.53 M(+12.2%) |
Sep 2015 | - | -$5.58 M(-20.5%) | -$21.87 M(+5.2%) |
Jun 2015 | - | -$7.03 M(+54.1%) | -$20.79 M(+27.5%) |
Mar 2015 | - | -$4.56 M(-2.8%) | -$16.30 M(-0.5%) |
Dec 2014 | -$16.38 M(-12.6%) | -$4.69 M(+4.2%) | -$16.38 M(-13.8%) |
Sep 2014 | - | -$4.50 M(+77.2%) | -$19.00 M(+6.0%) |
Jun 2014 | - | -$2.54 M(-45.3%) | -$17.93 M(-6.4%) |
Mar 2014 | - | -$4.65 M(-36.4%) | -$19.15 M(+2.2%) |
Dec 2013 | -$18.74 M(+0.6%) | -$7.31 M(+112.8%) | -$18.74 M(+63.9%) |
Sep 2013 | - | -$3.43 M(-8.7%) | -$11.43 M(+42.9%) |
Jun 2013 | - | -$3.76 M(-11.1%) | -$8.00 M(+88.9%) |
Mar 2013 | - | -$4.23 M | -$4.23 M |
Dec 2012 | -$18.63 M | - | - |
FAQ
- What is ContraFect annual EBITDA?
- What is the all time high annual EBITDA for ContraFect?
- What is ContraFect annual EBITDA year-on-year change?
- What is ContraFect quarterly EBITDA?
- What is the all time high quarterly EBITDA for ContraFect?
- What is ContraFect quarterly EBITDA year-on-year change?
- What is ContraFect TTM EBITDA?
- What is the all time high TTM EBITDA for ContraFect?
- What is ContraFect TTM EBITDA year-on-year change?
What is ContraFect annual EBITDA?
The current annual EBITDA of CFRX is -$56.73 M
What is the all time high annual EBITDA for ContraFect?
ContraFect all-time high annual EBITDA is -$16.38 M
What is ContraFect annual EBITDA year-on-year change?
Over the past year, CFRX annual EBITDA has changed by -$9.62 M (-20.41%)
What is ContraFect quarterly EBITDA?
The current quarterly EBITDA of CFRX is -$6.64 M
What is the all time high quarterly EBITDA for ContraFect?
ContraFect all-time high quarterly EBITDA is -$2.54 M
What is ContraFect quarterly EBITDA year-on-year change?
Over the past year, CFRX quarterly EBITDA has changed by +$7.50 M (+53.06%)
What is ContraFect TTM EBITDA?
The current TTM EBITDA of CFRX is -$30.05 M
What is the all time high TTM EBITDA for ContraFect?
ContraFect all-time high TTM EBITDA is -$4.23 M
What is ContraFect TTM EBITDA year-on-year change?
Over the past year, CFRX TTM EBITDA has changed by +$34.06 M (+53.12%)